This quarter our collective businesses delivered mid-teens earnings-per-share growth, including continued strong double-digit operational sales growth in global nutritionals, global vascular and worldwide pharmaceuticals. We saw significant profitability improvements in our vascular and diagnostics segments also. About Abbott Abbott is a global, broad-based health care company devoted to the discovery, development, advertising and produce of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 72, 000 people and markets its products in a lot more than 130 countries.. Abbott Reviews 16 Percent Earnings Growth in First Quarter Abbott has announced financial outcomes for the first one fourth ended March 31, 2009.World Alzheimer Report key findings: Related StoriesMayo Clinic's Florida campus awarded NIH grant to identify vascular risk factors in ageing and dementiaBU researcher gets prestigious fellowship to launch new project for those who have dementiaOlder adults with dementia make more frequent visits to emergency departmentsWorldwide costs of dementia will exceed 1 percent of global GDP this year 2010 – at US$604 billion. About 70 percent of the expenses occur in Western Europe and North America. If dementia treatment were a national country, it could be the world’s 18th largest economy. The number of people with dementia will dual by 2030, and more than triple by 2050 The expenses of caring for people with dementia will rise quicker compared to the prevalence.